Cancer is the second commonest killer of people in Pakistan. Thus it represents a huge disease burden on our nation. Surgical Oncology Society Pakistan (SOS-PK) is the main representative body of surgeons from Pakistan with interest in cancer surgery.

24th Shaukat Khanum Cancer Symposium October 24 - 26, 2025 (Hybrid Meeting) Pearl Continental Hotel Lahore, Pakistan #surgicaloncology 🇵🇰 #CancerCare #excellenceinsurgery @ZubairKhanzada1 @YSAC_PK @PkSurgeons

A superb fellowship opportunity commencing October 2026. Highly recommend. Please contact Mr Jurgen Mulsow (details below) @ESSOnews @PSOGI_EC @RCSI_Irl @Matersurgery @escp_tweets @FaheezM @AndreasBrandl8 @BasingstokePmi @DrSGlezMoreno @alarjosan @ISSPP1 @SOS_Pk @indepso

Kudos to #ATLS #Pakistan🇵🇰 A huge thank you to ATLS Educator Prof @asgharnaqi @SOS_Pk @YSAC_PK

Thank you @ESSOnews for an outstanding #ESSO44 in Gothenburg 🇸🇪 … truly an inspiring meeting of surgical oncologists worldwide! 👏 Farewell Gothenburg, and see you all in Madrid 🇪🇸 for #ESSO45! @SOS_Pk @YSAC_PK

Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis - PMC

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Elinor Bexe Lindskog 🇸🇪 The Immune Microenvironment in Peritoneal Metastases The immune landscape of peritoneal metastases differs from other metastatic sites. Peritoneal lesions show a fibro-inflammatory,

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Anders Thornell 🇸🇪 Sahlgrenska Mock Debate: Should follow-up for operated GIST tumors be escalated or de-escalated? Two experts go head-to-head over early relapse detection, second cancer risk, scan burden, and

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing This presentation reviews the current AJCC staging system for melanoma, outline the present state of staging practices, and

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Laura Lorenzon 🇮🇹 Investigation and Management of GI Symptoms After Surgery Thousands of patients currently live with a diagnosis of gastric cancer. Gastrointestinal symptoms are related to the cancer itself, with

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Lasma Nikolaisone 🇱🇻 The Testimonial of a Young Rectal Cancer Patient Rectal cancer treatment saves lives — but what follows is often a silent struggle with side effects that few discuss openly. In her talk, Lāsma

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Øyvind Bruland 🇳🇴 Oslo Alpha-emitting Radionuclide-Therapy with Bio-degradable microparticles injected intra-peritoneally A brief outline on selected aspects of the tumorbiology & epidemiology of peritoneal metastases

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Wim Ceelen 🇧🇪 Ghent Physically Enhanced IP Drug Delivery Tumor tissue penetration is very limited after intraperitoneal drug delivery, hampering its clinical efficacy. During this talk, I discuss how physical methods

Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Stefan Stättner 🇦🇹 Discussing Robotic Liver Surgery Robotic liver surgery is moving from the acceptance to the standardization phase with emerging experience and higher availability of robotic systems. The major

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Markus Mille 🇩🇪 Discussing: Robotic Single Port SP Surgery Robotic single-port (SP) surgery, enabled by the da Vinci SP system, represents an advanced evolution in robotic-assisted surgery by allowing true single-site

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Melanoma Staging and Molecular Testing This presentation reviews the current AJCC staging system for melanoma, outline the present state of staging practices, and

Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Oliver Gimm 🇸🇪 Updates on Partial Adrenalectomy for Medullary and Cortical Adrenal Tumours Partial adrenalectomy serves primarily to preserve adrenal function in patients with bilateral adrenal disease. For medullary

Day 1 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma to the Live This presentation examines the use of percutaneous hepatic perfusion (PHP) for the treatment

Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jakob Hedberg of Uppsala🇸🇪 dMMR tumors in clinical practice? Do we have evidence for neoadjuvant strategy? In oesophageal and gastric cancer, tumours with defect mismatched repair genes (dMMR) are in minority but

Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Jonathan Zager 🇺🇸 Moffit Cancer Center Presenting on Localisation and Resection of #Melanoma Metastases This presentation addresses strategies for detecting metastatic disease following neoadjuvant therapy and emphasize

Day 2 of #ESSO44 in Gothenburg Sweden, Presentation by Dr. Philipp Lennartsson 🇸🇪 Best Swedish Abstracts: The Role of Tumor Location in Pancreatic Cancer on Perioperative Outcome and Long-Term Survival Analysis of survival in patients with resected pancreatic cancer from the